ArticleBMC pulmonary medicine2025
Comparison of PENTAX EB-1970UK and EB19-J10U ultrasound bronchoscopes for EBUS-TBNA in the diagnosis of mediastinal lymphadenopathy.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimEndobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a widely used technique for evaluating mediastinal lymphadenopathy. However, limited data exist regarding the impact of different ultrasound bronchoscope models on procedural outcomes. This study assessed the technical performance, diagnostic efficacy, and safety of two PENTAX bronchoscopes-EB-1970UK and EB19-J10U-in EBUS-TBNA. PATIENTS AND
methodsThis retrospective study included patients with mediastinal lymphadenopathy who underwent EBUS-TBNA at Shengjing Hospital, China Medical University between January 2023 and March 2024. Patients were divided into two groups based on the bronchoscope used: EB-1970UK (n=73) and EB19-J10U (n=75). The groups were compared for specimen adequacy, complication rates, pathological positivity, diagnostic yield, and the predictive value of elastography in differentiating benign from malignant lymph nodes.
resultsThe specimen adequacy rate was significantly lower in the EB-1970UK group (89.77% vs. 97.03%, P < 0.05). The incidence of severe cough complications was higher in the EB-1970UK group (13.70% vs. 4.00%, P < 0.05). The pathological positivity rate (63.01% vs. 76.00%, P >0.05) and diagnostic yield (80.82% vs. 84.00%, P >0.05) were comparable. The strain ratio threshold for differentiating malignant from benign lymph nodes was 4.24 for EB19-J10Uand 2.115 for EB-1970UK, showing significant predictive value.
conclusionBoth bronchoscopes demonstrated high diagnostic accuracy and predictive value in elastography-assisted EBUS-TBNA for mediastinal lymphadenopathy. However, EB19-J10U provided better specimen adequacy and fewer severe cough complications, suggesting superior procedural efficiency and patient tolerance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.